- Home
- XERS vs DSL Comparison
XERS vs DSL Comparison
Compare XERS & DSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- DSL
- Stock Information
- Founded
- XERS 2005
- DSL 2013
- Country
- XERS United States
- DSL United States
- Employees
- XERS N/A
- DSL N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- DSL Trusts Except Educational Religious and Charitable
- Sector
- XERS Health Care
- DSL Finance
- Exchange
- XERS Nasdaq
- DSL Nasdaq
- Market Cap
- XERS 1.3B
- DSL 1.4B
- IPO Year
- XERS 2018
- DSL N/A
- Fundamental
- Price
- XERS $7.64
- DSL $11.54
- Analyst Decision
- XERS Strong Buy
- DSL
- Analyst Count
- XERS 7
- DSL 0
- Target Price
- XERS $9.43
- DSL N/A
- AVG Volume (30 Days)
- XERS 3.0M
- DSL 704.7K
- Earning Date
- XERS 11-06-2025
- DSL 01-01-0001
- Dividend Yield
- XERS N/A
- DSL 11.45%
- EPS Growth
- XERS N/A
- DSL N/A
- EPS
- XERS N/A
- DSL N/A
- Revenue
- XERS $266,137,000.00
- DSL N/A
- Revenue This Year
- XERS $43.89
- DSL N/A
- Revenue Next Year
- XERS $20.40
- DSL N/A
- P/E Ratio
- XERS N/A
- DSL N/A
- Revenue Growth
- XERS 42.05
- DSL N/A
- 52 Week Low
- XERS $2.82
- DSL $10.58
- 52 Week High
- XERS $10.08
- DSL $13.00
- Technical
- Relative Strength Index (RSI)
- XERS 36.31
- DSL 27.20
- Support Level
- XERS $7.00
- DSL $11.50
- Resistance Level
- XERS $10.08
- DSL $11.62
- Average True Range (ATR)
- XERS 0.53
- DSL 0.11
- MACD
- XERS -0.26
- DSL -0.01
- Stochastic Oscillator
- XERS 23.38
- DSL 22.91
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About DSL DoubleLine Income Solutions Fund of Beneficial Interests
DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.